The Anatomical Basis and Operational Guidelines of the Puncture Path

The clinical application of subcutaneous injection needles is based on precise anatomical knowledge and standardized operational science. From a histological perspective, human skin is composed of the epidermis (50-100 μm), dermis (1-2 mm), and subcutaneous tissue. Different injection methods target different tissue layers. Intradermal injection (such as the tuberculin test) uses a 26-30G, 3-10 mm short needle, inserted at a 5-15° angle between the epidermis and dermis, forming a 5-10 mm pustule. This area has a rich lymphatic network but few blood vessels, and the drug absorption is slow, making it suitable for sensitivity tests. Subcutaneous injection (such as insulin) employs a 28-31G, 4-8 mm needle, inserted at a 45-90° angle into the subcutaneous fat layer. Here, the blood vessels are moderately distributed, and the absorption rate is moderate, making it suitable for drugs that need sustained action.

The anatomical considerations for intramuscular injection are more complex. For adults, a 22-25G needle with a length of 25-38 mm is commonly used, and it is inserted vertically at a 90° angle into the muscle fibers. The injection depth in the deltoid muscle area should be controlled at 16-25 mm to avoid injuring the radial nerve; in the gluteus maximus area, the "cross division method" is adopted, with the needle inserted in the outer upper quadrant, with a depth of 30-40 mm, to avoid the sciatic nerve; the thickness of the vastus lateralis muscle is usually 20-30 mm, making it an ideal site for injection in children. Ultrasound studies have shown that there are significant differences in muscle thickness among different body types: obese individuals have a subcutaneous fat layer of up to 30-50 mm, and a 50 mm-long needle is required to reach the muscle layer; for thin individuals, a depth of only 16 mm may be sufficient. During the puncture, the "Z-pathway" technique should be used: first, pull the skin to one side by 2 cm, then inject, and release the hand to allow the needle path to shift between the tissue layers to prevent the backflow of the drug solution.

Venipuncture involves hemodynamic factors. For peripheral venipuncture, a 20-22G needle with a length of 25-32 mm is commonly used, inserted at an angle of 15-30 degrees. The relationship between blood flow velocity and needle diameter conforms to Poiseuille's law: a 20G needle (inner diameter 0.603 mm) has a flow rate of approximately 60 ml/min under standard gravity, while a 24G needle (inner diameter 0.311 mm) drops to 20 ml/min. The puncture point should be selected 1-2 cm downstream of the venous bifurcation to avoid hemolysis caused by turbulence. The latest ultrasound-guided technology can display the needle tip position in real time, increasing the success rate of one-time puncture from the traditional 70% to 95%. For fragile blood vessels, the "shallow angle progressive method" is adopted: first insert 10° into the skin, then advance 3-5 mm under the skin before entering the blood vessel at a 20° angle, reducing damage to the posterior wall of the blood vessel.

The special injection techniques have their own physical principles. In intra-articular injections (such as for the knee joint), a 21-23G needle with a length of 25-40 mm is used. The use of the viscous elasticity of the synovial fluid to create a "rebound sensation" helps determine the needle's entry into the joint cavity. For epidural anesthesia, an 18-20G Tuohy needle is employed, with a unique curved needle tip (Huber point design) guiding the catheter in a specific direction. For intravitreal injections, a 30-32G ultra-fine needle is used, with the needle inserted 3.5-4 mm posterior to the corneal limbus. The self-sealing property of the eyeball wall allows a needle hole with a diameter of ≤0.3 mm to close seamlessly without any fusion issues. These precise operations require not only precise sizes of the needles but also specific mechanical properties: the joint puncture needle needs to be sufficiently rigid to penetrate the joint capsule, while the vitreous injection needle requires flexibility to adapt to the curvature of the eyeball.

Injection kinetics studies reveal optimization strategies. Injection speed affects drug distribution: the recommended speed for subcutaneous insulin injection is 0.1 ml/s; injecting too fast can form a "drug pool" leading to unstable absorption; for intramuscular vaccines, a speed of 0.5 ml/s is recommended to generate moderate tissue pressure to promote the recruitment of immune cells. There are specific considerations for needle retention time: after subcutaneous injection, the needle should be left in place for 10 seconds to prevent 0.02-0.05 ml of drug remaining in the needle channel; after injecting the anticoagulant, a 30-second retention is necessary to avoid the drug being pushed out by tissue pressure. There is also a certain art to the needle withdrawal angle: slowly withdrawing along the puncture axis can reduce tissue damage; rapid and oblique withdrawal may cut microvessels.